Skip to content

Alto Ingredients, Inc. ALTO Indefinite-Lived Research and Development Assets

Indefinite-Lived Research and Development Assets at other companies

MGP Ingredients logo
MGP IngredientsMGPI
Oil-Dri Corporation of America logo
Oil-Dri Corporation of AmericaODC
HWK
HawkinsHWKN

Other financials

Income statement

See full
Revenue$224.7M-0.8%
Gross profit$9.2M+610%
Operating income$2.5M+128%
Net income$4.3M+137%
EPS (diluted)$0.05+131%

Balance sheet

See full
Cash & equivalents$21.6M-20.3%
Total debt$91.3M-30.5%
Total equity$249.9M+16.8%
Total assets$386.3M-4.0%

Cash flow

See full
Operating cash flow$4.2M+123%
CapEx$909.0K+70.9%
Free cash flow$3.3M+118%

Valuation

See full
Market cap$385.88M+342%
Enterprise value$455.51M+138%
P/E13.2×
P/S0.4×+0.3×

Profitability

See full
Gross margin5%
Operating margin2.1%+1.2pp
Net margin3.2%+1.9pp
FCF margin3.4%

Returns & leverage

See full
Return on equity12.6%+7.6pp
Debt / equity0.4×-0.2×
Current ratio3.8×+0.9×

Where this comes from

Reported directly by Alto Ingredients, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment.

The official record: Alto Ingredients, Inc.’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alto Ingredients, Inc.'s indefinite-lived research and development assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alto Ingredients, Inc.'s indefinite-lived research and development assets?
Alto Ingredients, Inc. (ALTO) reported indefinite-lived research and development assets of $3.74M in Q4 2025.
What is the long-term trend for Alto Ingredients, Inc.'s indefinite-lived research and development assets?
Over 2 years (2023 to 2025), Alto Ingredients, Inc.'s indefinite-lived research and development assets has grown at a 0.0% compound annual growth rate (CAGR), from $3.74M to $3.74M.
What does indefinite-lived research and development assets mean?
The carrying value of acquired in-process research and development assets that have not yet reached commercial viability. These assets are not amortized because their useful life is currently indeterminate, pending the completion or abandonment of the underlying projects. This metric represents the company's investment in future innovation and potential long-term growth drivers.